Dietary Intervention for Cardiovascular Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-23

Study Completion Date

2023-02-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Incidence of cardiometabolic disease (CMD) continues to rise, which consumes huge medical resources in Taiwan. The effectiveness of dietary therapy for CMD has not been locally evaluated in detail. CVD is an important risk factor for dementia. At the present time, there is no effective treatment available for dementia. Early prevention is extremely important. Our previous studies have shown that Taiwanese dementia protective diet is very similar to cardiovascular prevention and control diet, meaning that effective dietary therapy may not only control CVD but also prevent dementia development. Therefore, this study intends to document the effects of dietary intervention on cardiovascular disease risk factor control, the long-term outcomes on the occurrence of cardiovascular events, and the maintenance of cognitive function for patients with coronary artery disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Chinese Heart Healthy Diet for People With High Cardiovascular Risk in China (DECIDE-Diet)

NCT03882645

Cardiovascular Disease Diet Modification Randomized Controlled Trial

TERMINATED NA

Effects of Nutritional Counseling Regularity on the Risk of Cardiovascular Diseases

NCT05092087

Cerebrovascular Disease

COMPLETED

Vegetarian Diet and Chronic Degenerative Diseases

NCT03470584

Dementia Depression Cardiovascular Diseases +5 more

COMPLETED

Dietary Effects on Lipoproteins and Thrombogenic Activity

NCT00000538

Cardiovascular Diseases Coronary Disease Coronary Heart Disease Risk Reduction +4 more

COMPLETED PHASE3

Modulation of Cardiovascular Risk Factors by the Diet

NCT02637778

Cardiovascular Diseases

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

usual medical management

with regular doctor visits every 3 months

Group Type PLACEBO_COMPARATOR

control:usual medical management

Intervention Type OTHER

with regular doctor visits every 3 months

usual medical management+individual dietary consultation

with regular doctor visits every 3 months and dietitian visits every 3 months until meeting dietary recommendation or reaching 3 years limit

Group Type EXPERIMENTAL

control:usual medical management

Intervention Type OTHER

with regular doctor visits every 3 months

intervention 1:usual medical management+individual dieting consultation

Intervention Type BEHAVIORAL

with regular doctor visits every 3 months and dietitian visits every 3 months

usual medical management+individual dietary consultation+ daily tea drinking

with regular doctor visits every 3 months, dietitian visits every 3 months until meeting dietary recommendation or reaching 3 years limit, and daily tea drinking

Group Type EXPERIMENTAL

control:usual medical management

Intervention Type OTHER

with regular doctor visits every 3 months

intervention 1:usual medical management+individual dieting consultation

Intervention Type BEHAVIORAL

with regular doctor visits every 3 months and dietitian visits every 3 months

intervention 2:usual medical management+individual dieting consultation+ daily tea drinking

Intervention Type BEHAVIORAL

with regular doctor visits every 3 months and dietitian visits every 3 months and daily tea drinking

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

control:usual medical management

with regular doctor visits every 3 months

Intervention Type OTHER

intervention 1:usual medical management+individual dieting consultation

with regular doctor visits every 3 months and dietitian visits every 3 months

Intervention Type BEHAVIORAL

intervention 2:usual medical management+individual dieting consultation+ daily tea drinking

with regular doctor visits every 3 months and dietitian visits every 3 months and daily tea drinking

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Have received percutaneous transluminal coronary artery surgery.
2. Stable drug control for more than one month

Exclusion Criteria

1. Suffer from cancer and undergo chemotherapy or surgery within one year.
2. Those who have a major illness in hospital within one year.
3. Those with kidney disease stage 5 (inclusive) or above
4. Those whose life expectancy does not exceed half a year
5. Patients with diagnosed dementia
6. Those who do not want to be tracked

Minimum Eligible Age

45 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No